ISSX Africa Workshop

Marjoleen Nijsen

Marjoleen Nijsen holds a Ph.D. in Pharmacology from the faculty of Medicine at the University of Utrecht, the Netherlands. Since then, she has focused her pharmacology career in the areas of Neuroscience, Cardiovascular and Gastrointestinal Emerging Diseases. At Johnson & Johnson in Belgium she switched her professional focus and continued her career in the field of Drug Metabolism and Pharmacokinetics (DMPK). She found her passion in combining both areas of expertise and built a newly formed team responsible for mechanistic pharmacokinetic/pharmacodynamic (PKPD) and physiological-based PK (PBPK) modeling. 

In 2008, Marjoleen re-located to Germany and joined Abbott/AbbVie, providing local DMPK and translational modeling support for Neuroscience Discovery. In 2010, she re-located to the US to accept a more global role as Director of the Global Translational Modeling & Simulation group, supporting drug discovery and development. In the following years, she built a global high-performing team responsible for generating DMPK/ADME data and providing quantitative systems pharmacology (QSP) and translational PBPK/PD models across therapeutic areas including oncology, immunology, neuroscience and infectious diseases. In 2018, she assumed her current role as VP of QTAS (Quantitative, Translational and ADME Sciences) and expanded her responsibilities by global leadership of (non)regulated bioanalysis (BA) support and biomarker assay development.